Liposomal bupivacaine for pain after gynecologic cancer surgery
Treatments studied
Part of Cancer, Pain, Women’s health & pregnancy clinical trials.
This trial tests whether a long-acting numbing medication (liposomal bupivacaine) injected into the abdominal wall can reduce pain after laparoscopic surgery for gynecologic cancer. If effective, it may help patients recover with less discomfort and fewer painkillers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for laparoscopic surgery for gynecologic cancer (not emergency surgery).
- You are between 18 and 64 years old.
- You are in generally good health (ASA class I, II, or III — your anesthesiologist can determine this).
- You are fully awake and alert (Glasgow Coma Scale score of 15).
- You do not have any of the following: chronic pain, heart block, unstable heart disease, stomach ulcer or bleeding, diabetes requiring insulin, bleeding disorders, severe liver or kidney problems, a history of mental illness or current psychiatric medication, alcohol or drug abuse, chronic opioid use, pregnancy or breastfeeding, extreme weight (BMI under 15 or over 35), or allergy to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a long-acting painkiller injected during surgery to see if it reduces pain after keyhole (laparoscopic) procedures like gallbladder removal, hernia repair, or appendix removal. It may help you need fewer opioids and recover more comfortably.
This trial is testing if a special numbing medicine called liposomal bupivacaine, given as a nerve block during surgery, can help reduce pain after laparoscopic procedures like gallbladder removal or hernia repair. It might help you feel better with less need for strong painkillers.
This trial tests if a long-acting numbing medicine called liposomal bupivacaine can reduce pain after video-assisted lung surgery. It aims to help patients feel better after the procedure with less need for other painkillers.
This trial tests a long-acting numbing medication (liposomal bupivacaine) injected around abdominal muscles during laparoscopic gallbladder removal to reduce pain after surgery. The goal is to see if it provides better pain control compared to standard approaches.
This trial tests whether a numbing medicine (liposomal bupivacaine) injected near the ribs can reduce pain after lung surgery. If you qualify, you may experience less pain and need fewer painkillers after your operation.
This trial tests if a long-lasting numbing medicine placed near the surgical site can reduce pain after a specific type of brain surgery. It may help patients recover more comfortably.
Hear when a new Laparoscopic Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.